Dr. Nina Engelhardt has been appointed vice president of Scientific Innovation at CROnos Clinical Consulting. Dr. Engelhardt has more than 20 years of experience with trial methodology and clinical assessment aimed at increasing the success rate of placebo-controlled CNS trials.
Prior to joining the company, Dr. Engelhardt served as senior clinical trainer and research scientist for MedAvante and senior therapeutic area associate for new antidepressants at Eli Lilly. She has also served as a clinical research associate in the division of Clinical Psychopharmacology, at Tufts-New England Medical Center.
"Nina is an exciting addition to our clinical team. We look forward to tapping into her expertise to deliver an improved product to our customers," said Guillermo Di Clemente, president and founder, CROnos. "Her diverse experience provides an outstanding view of our market and its current and future innovations."